Krystal Biotech, Inc. (KRYS) Financials

NASDAQ Currency in USD Disclaimer

$158.52

south_east -$2.31 (-1.44%)
Day's range
$156.69
Day's range
$162.11

KRYS Income statement / Annual

Last year (2023), Krystal Biotech, Inc.'s total revenue was $50.70 M, and the percentage change from the previous year is not available. In 2023, Krystal Biotech, Inc.'s net income was $10.93 M. See Krystal Biotech, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $50.70 M $0.00 $0.00 $0.00 $0.00 $1.03 M $0.00 $0.00
Cost of Revenue $3.09 M $4.05 M $2.77 M $1.85 M $974,000.00 $141,000.00 $23,000.00 $2,000.00
Gross Profit $47.61 M -$4.05 M -$2.77 M -$1.85 M -$974,000.00 $886,000.00 -$23,000.00 -$2,000.00
Gross Profit Ratio 0.94 0 0 0 0 0.86 0 0
Research and Development Expenses $46.43 M $42.46 M $27.88 M $17.94 M $15.62 M $7.76 M $3.21 M $741,000.00
General & Administrative Expenses $0.00 $77.74 M $40.39 M $15.06 M $6.47 M $4.16 M $1.56 M $402,000.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $98.40 M $77.74 M $40.39 M $15.06 M $6.47 M $4.16 M $1.56 M $402,000.00
Other Expenses $12.50 M $25.00 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $157.33 M $120.20 M $68.28 M $33.00 M $22.08 M $11.92 M $4.77 M $1.14 M
Cost And Expenses $147.93 M $120.20 M $68.28 M $33.00 M $22.08 M $11.92 M $4.77 M $1.14 M
Interest Income $22.62 M $5.22 M $197,000.00 $832,000.00 $2.99 M $0.00 $0.00 $0.00
Interest Expense $0.00 $5.22 M $1.49 M $0.00 $0.00 $1.03 M $3.15 M $7,000.00
Depreciation & Amortization $5.01 M $4.05 M $2.77 M $1.85 M $974,000.00 $141,000.00 $23,000.00 $2,000.00
EBITDA $17.90 M -$145.20 M -$65.31 M -$30.32 M -$18.11 M -$10.75 M -$4.63 M -$1.14 M
EBITDA Ratio 0.35 0 0 0 0 -11.47 0 0
Operating Income Ratio -2.16 0 0 0 0 -11.6 0 0
Total Other Income/Expenses Net $122.62 M $5.22 M -$1.30 M $832,000.00 $2.99 M $1.03 M -$3.15 M -$7,000.00
Income Before Tax $12.90 M -$139.98 M -$69.57 M -$32.17 M -$19.09 M -$10.89 M -$7.92 M -$1.15 M
Income Before Tax Ratio 0.25 0 0 0 0 -10.6 0 0
Income Tax Expense $1.97 M $34.05 M $2.73 M $1.64 M $576,140.00 -$20,141.00 $0.00 $0.00
Net Income $10.93 M -$139.98 M -$69.57 M -$32.17 M -$19.09 M -$10.89 M -$7.92 M -$1.15 M
Net Income Ratio 0.22 0 0 0 0 -10.6 0 0
EPS 0.4 -5.49 -3.13 -1.71 -1.2 -0.97 -1.48 -0.27
EPS Diluted 0.39 -5.49 -3.13 -1.71 -1.2 -0.97 -1.48 -0.27
Weighted Average Shares Out $27.15 M $25.49 M $22.20 M $18.79 M $15.90 M $11.20 M $5.36 M $4.28 M
Weighted Average Shares Out Diluted $27.75 M $25.49 M $22.20 M $18.79 M $15.90 M $11.20 M $5.36 M $4.28 M
Link